BioNexus Gene Lab Corp (BGLC) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No case yet. It builds on the next filing, report or 13F period.
BioNexus Gene Lab Corp has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 8071, Services-Medical Laboratories, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
N/A
3 managers report a position worth $28,199 between them, and 1 of them hold 80% of it.
BGLC (BioNexus Gene Lab Corp) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 1.46 at 9:30 am ET, low 1.46 at 9:30 am ET.
BioNexus Gene Lab Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Medical Laboratories